Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

TERN holding history

Terns Pharmaceuticals, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TERN overviewAll 13F holders of TERNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of TERN by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−2,316,544−100.0%Sold outHolders
Q1 20262,316,544$122.2M<0.1%+219,902+10.5%AddedHolders
Q4 20252,096,642$84.7M<0.1%+382,090+22.3%AddedHolders
Q3 20251,714,552$12.9M<0.1%+81,203+5.0%AddedHolders
Q2 20251,633,349$6.09M<0.1%+59,145+3.8%AddedHolders
Q1 20251,574,204$4.35M<0.1%+57,726+3.8%AddedHolders
Q4 20241,516,478$8.40M<0.1%+308,999+25.6%AddedHolders
Q3 20241,207,479$10.1M<0.1%+85,617+7.6%AddedHolders
Q2 20241,121,862$7.64M<0.1%+255,941+29.6%AddedHolders
Q1 2024865,921$5.68M<0.1%+25,462+3.0%AddedHolders
Q4 2023840,459$5.46M<0.1%+52,344+6.6%AddedHolders
Q3 2023788,115$3.96M<0.1%+604+0.1%AddedHolders
Q2 2023787,511$6.89M<0.1%+482,795+158.4%AddedHolders
Q1 2023304,716$3.61M<0.1%+127,068+71.5%AddedHolders
Q4 2022177,648$1.81M<0.1%+8,800+5.2%AddedHolders
Q3 2022168,848$994.0K<0.1%+89,524+112.9%AddedHolders
Q2 202279,324$196.0K<0.1%−99,987−55.8%ReducedHolders
Q1 2022179,311$532.0K<0.1%−1,624−0.9%ReducedHolders
Q4 2021180,935$1.28M<0.1%−12,401−6.4%ReducedHolders
Q3 2021193,336$2.01M<0.1%+50,267+35.1%AddedHolders
Q2 2021143,069$1.75M<0.1%+12,806+9.8%AddedHolders
Q1 2021130,263$2.87M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.